

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | triglyceride catabolic process (GO:0019433) | 5.99619654 |
| 2 | low-density lipoprotein particle clearance (GO:0034383) | 5.97222633 |
| 3 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 5.42149479 |
| 4 | neutral lipid catabolic process (GO:0046461) | 5.38601214 |
| 5 | acylglycerol catabolic process (GO:0046464) | 5.38601214 |
| 6 | regulation of sequestering of triglyceride (GO:0010889) | 5.37585020 |
| 7 | keratan sulfate catabolic process (GO:0042340) | 5.17152712 |
| 8 | ethanol oxidation (GO:0006069) | 4.58340606 |
| 9 | extracellular fibril organization (GO:0043206) | 4.35021534 |
| 10 | protein heterotrimerization (GO:0070208) | 4.31431788 |
| 11 | complement activation, alternative pathway (GO:0006957) | 4.24100423 |
| 12 | transcytosis (GO:0045056) | 4.15992952 |
| 13 | glomerulus development (GO:0032835) | 4.14571051 |
| 14 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 4.14107847 |
| 15 | ovulation from ovarian follicle (GO:0001542) | 4.07293826 |
| 16 | peripheral nervous system axon ensheathment (GO:0032292) | 4.01633114 |
| 17 | myelination in peripheral nervous system (GO:0022011) | 4.01633114 |
| 18 | smooth muscle tissue development (GO:0048745) | 3.84957369 |
| 19 | collagen fibril organization (GO:0030199) | 3.80995685 |
| 20 | glycerolipid catabolic process (GO:0046503) | 3.78773496 |
| 21 | dermatan sulfate biosynthetic process (GO:0030208) | 3.73286818 |
| 22 | response to dietary excess (GO:0002021) | 3.73169686 |
| 23 | ethanol metabolic process (GO:0006067) | 3.66403222 |
| 24 | regulation of gonadotropin secretion (GO:0032276) | 3.64419928 |
| 25 | kidney mesenchyme development (GO:0072074) | 3.61741351 |
| 26 | polyol transport (GO:0015791) | 3.58420250 |
| 27 | fibril organization (GO:0097435) | 3.57910837 |
| 28 | lymph vessel development (GO:0001945) | 3.53507645 |
| 29 | dermatan sulfate metabolic process (GO:0030205) | 3.51462807 |
| 30 | positive regulation of respiratory burst (GO:0060267) | 3.49740453 |
| 31 | fatty acid homeostasis (GO:0055089) | 3.49420299 |
| 32 | extracellular matrix assembly (GO:0085029) | 3.47607802 |
| 33 | venous blood vessel morphogenesis (GO:0048845) | 3.47159311 |
| 34 | endocardial cushion morphogenesis (GO:0003203) | 3.45414079 |
| 35 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 3.41632327 |
| 36 | triglyceride homeostasis (GO:0070328) | 3.40623351 |
| 37 | acylglycerol homeostasis (GO:0055090) | 3.40623351 |
| 38 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.40585591 |
| 39 | glomerular basement membrane development (GO:0032836) | 3.40355600 |
| 40 | plasma lipoprotein particle clearance (GO:0034381) | 3.39831652 |
| 41 | primary alcohol metabolic process (GO:0034308) | 3.33487640 |
| 42 | mesenchyme morphogenesis (GO:0072132) | 3.33467986 |
| 43 | negative regulation of gluconeogenesis (GO:0045721) | 3.33427581 |
| 44 | detection of molecule of bacterial origin (GO:0032490) | 3.32545577 |
| 45 | cell migration involved in heart development (GO:0060973) | 3.32268550 |
| 46 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.31471035 |
| 47 | regulation of lipoprotein metabolic process (GO:0050746) | 3.29469199 |
| 48 | lipid storage (GO:0019915) | 3.29233594 |
| 49 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.28413059 |
| 50 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.27441514 |
| 51 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.27441514 |
| 52 | NADH metabolic process (GO:0006734) | 3.26835593 |
| 53 | positive regulation of macrophage cytokine production (GO:0060907) | 3.25520562 |
| 54 | positive regulation of cholesterol efflux (GO:0010875) | 3.23833711 |
| 55 | positive regulation of glycolytic process (GO:0045821) | 3.23649265 |
| 56 | regulation of cardiac muscle cell differentiation (GO:2000725) | 3.23213879 |
| 57 | negative regulation of muscle hypertrophy (GO:0014741) | 3.22281455 |
| 58 | myofibril assembly (GO:0030239) | 3.19741628 |
| 59 | cell proliferation involved in kidney development (GO:0072111) | 3.17146133 |
| 60 | negative regulation of complement activation (GO:0045916) | 3.16637002 |
| 61 | bone trabecula formation (GO:0060346) | 3.14279044 |
| 62 | negative regulation of protein activation cascade (GO:2000258) | 3.12925000 |
| 63 | protein localization to cell surface (GO:0034394) | 3.12164537 |
| 64 | positive regulation of glomerulus development (GO:0090193) | 3.10875448 |
| 65 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.10812915 |
| 66 | regulation of triglyceride catabolic process (GO:0010896) | 3.09908917 |
| 67 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.09790136 |
| 68 | regulation of protein activation cascade (GO:2000257) | 3.09563583 |
| 69 | regulation of cholesterol storage (GO:0010885) | 3.07271245 |
| 70 | regulation of complement activation (GO:0030449) | 3.06962702 |
| 71 | negative regulation of myoblast differentiation (GO:0045662) | 3.05532153 |
| 72 | barbed-end actin filament capping (GO:0051016) | 3.05313563 |
| 73 | cardiac myofibril assembly (GO:0055003) | 3.05122324 |
| 74 | cGMP-mediated signaling (GO:0019934) | 3.04549865 |
| 75 | positive regulation of sterol transport (GO:0032373) | 3.03770267 |
| 76 | positive regulation of cholesterol transport (GO:0032376) | 3.03770267 |
| 77 | atrioventricular valve morphogenesis (GO:0003181) | 3.03657121 |
| 78 | metanephric mesenchyme development (GO:0072075) | 3.03282217 |
| 79 | diacylglycerol metabolic process (GO:0046339) | 3.02038061 |
| 80 | blood vessel maturation (GO:0001955) | 3.00663704 |
| 81 | positive regulation of lipid storage (GO:0010884) | 2.99172987 |
| 82 | negative regulation of cartilage development (GO:0061037) | 2.98849091 |
| 83 | endocrine hormone secretion (GO:0060986) | 2.97434014 |
| 84 | regulation of pigment cell differentiation (GO:0050932) | 2.97042828 |
| 85 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.95642513 |
| 86 | glomerular filtration (GO:0003094) | 2.92877512 |
| 87 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.90470262 |
| 88 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.90470262 |
| 89 | lipid particle organization (GO:0034389) | 2.90381184 |
| 90 | nucleoside diphosphate catabolic process (GO:0009134) | 2.89991634 |
| 91 | energy homeostasis (GO:0097009) | 2.88264400 |
| 92 | positive regulation of glucose import (GO:0046326) | 2.85638188 |
| 93 | brown fat cell differentiation (GO:0050873) | 2.85581891 |
| 94 | opsonization (GO:0008228) | 2.85095490 |
| 95 | cellular response to epinephrine stimulus (GO:0071872) | 2.84967746 |
| 96 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.84946615 |
| 97 | primary alcohol catabolic process (GO:0034310) | 2.84912122 |
| 98 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.84438573 |
| 99 | regulation of plasminogen activation (GO:0010755) | 2.84387351 |
| 100 | regulation of phospholipase A2 activity (GO:0032429) | 2.84238647 |
| 101 | chondroitin sulfate catabolic process (GO:0030207) | 2.82640670 |
| 102 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.82412052 |
| 103 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.81767481 |
| 104 | white fat cell differentiation (GO:0050872) | 2.81590921 |
| 105 | regulation of relaxation of muscle (GO:1901077) | 2.80676282 |
| 106 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.79355539 |
| 107 | negative regulation of norepinephrine secretion (GO:0010700) | 2.78655092 |
| 108 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.78226830 |
| 109 | skeletal muscle adaptation (GO:0043501) | 2.77244485 |
| 110 | negative regulation of granulocyte differentiation (GO:0030853) | 2.76375129 |
| 111 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.76310939 |
| 112 | regulation of macrophage cytokine production (GO:0010935) | 2.75799426 |
| 113 | response to phenylpropanoid (GO:0080184) | 2.75310105 |
| 114 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.75181098 |
| 115 | regulation of interleukin-8 secretion (GO:2000482) | 2.75123798 |
| 116 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.74256918 |
| 117 | extracellular regulation of signal transduction (GO:1900115) | 2.73218725 |
| 118 | extracellular negative regulation of signal transduction (GO:1900116) | 2.73218725 |
| 119 | regulation of skeletal muscle contraction (GO:0014819) | 2.73024690 |
| 120 | negative regulation of protein autophosphorylation (GO:0031953) | 2.70780663 |
| 121 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.70632471 |
| 122 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.70360586 |
| 123 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.70070105 |
| 124 | regulation of insulin-like growth factor receptor signaling pathway (GO:0043567) | 2.70053075 |
| 125 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.69272007 |
| 126 | valine metabolic process (GO:0006573) | 2.66843254 |
| 127 | regulation of cardiac muscle hypertrophy (GO:0010611) | 2.66561774 |
| 128 | fatty acid transmembrane transport (GO:1902001) | 2.65829081 |
| 129 | complement activation (GO:0006956) | 2.65743555 |
| 130 | cellular response to vitamin (GO:0071295) | 2.63972942 |
| 131 | triglyceride metabolic process (GO:0006641) | 2.63460807 |
| 132 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 2.63074245 |
| 133 | regulation of muscle hypertrophy (GO:0014743) | 2.62175175 |
| 134 | cornea development in camera-type eye (GO:0061303) | 2.61925687 |
| 135 | collagen metabolic process (GO:0032963) | 2.60388544 |
| 136 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.59099190 |
| 137 | nephron tubule development (GO:0072080) | 2.58366067 |
| 138 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.55891395 |
| 139 | response to epinephrine (GO:0071871) | 2.55391871 |
| 140 | collagen catabolic process (GO:0030574) | 2.55175998 |
| 141 | response to folic acid (GO:0051593) | 2.54150829 |
| 142 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 2.53367410 |
| 143 | virion attachment to host cell (GO:0019062) | 2.52834521 |
| 144 | adhesion of symbiont to host cell (GO:0044650) | 2.52834521 |
| 145 | cellular response to leptin stimulus (GO:0044320) | 2.52259309 |
| 146 | positive regulation of glucose transport (GO:0010828) | 2.52084386 |
| 147 | regulation of sterol transport (GO:0032371) | 2.51164490 |
| 148 | regulation of cholesterol transport (GO:0032374) | 2.51164490 |
| 149 | nephron epithelium development (GO:0072009) | 2.51030461 |
| 150 | retinol metabolic process (GO:0042572) | 2.50719156 |
| 151 | endothelium development (GO:0003158) | 2.50443892 |
| 152 | negative regulation of heart growth (GO:0061117) | 2.49530790 |
| 153 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.49530790 |
| 154 | import into cell (GO:0098657) | 2.48866301 |
| 155 | cellular response to BMP stimulus (GO:0071773) | 2.48814890 |
| 156 | response to BMP (GO:0071772) | 2.48814890 |
| 157 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.47789935 |
| 158 | definitive hemopoiesis (GO:0060216) | 2.47088160 |
| 159 | cell differentiation involved in metanephros development (GO:0072202) | 2.46962602 |
| 160 | regulation of actin filament-based movement (GO:1903115) | 2.46386994 |
| 161 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.46258343 |
| 162 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.45924112 |
| 163 | keratan sulfate biosynthetic process (GO:0018146) | 2.45392826 |
| 164 | regulation of myoblast differentiation (GO:0045661) | 2.41574130 |
| 165 | superoxide anion generation (GO:0042554) | 2.38801635 |
| 166 | positive regulation of vascular permeability (GO:0043117) | 2.38399223 |
| 167 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.36334311 |
| 168 | artery development (GO:0060840) | 2.35948737 |
| 169 | mesonephros development (GO:0001823) | 2.35565775 |
| 170 | endothelial cell proliferation (GO:0001935) | 2.34769367 |
| 171 | regulation of skeletal muscle fiber development (GO:0048742) | 2.33782696 |
| 172 | multicellular organismal catabolic process (GO:0044243) | 2.33699074 |
| 173 | multicellular organismal metabolic process (GO:0044236) | 2.33425025 |
| 174 | * extracellular matrix organization (GO:0030198) | 2.33408930 |
| 175 | renal tubule development (GO:0061326) | 2.32982293 |
| 176 | * extracellular structure organization (GO:0043062) | 2.32508262 |
| 177 | chondrocyte proliferation (GO:0035988) | 2.32446618 |
| 178 | face morphogenesis (GO:0060325) | 2.32181691 |
| 179 | cranial nerve structural organization (GO:0021604) | 2.31758531 |
| 180 | regulation of cell communication by electrical coupling (GO:0010649) | 2.31720098 |
| 181 | regulation of endothelial cell differentiation (GO:0045601) | 2.30772708 |
| 182 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.30260688 |
| 183 | endothelial cell morphogenesis (GO:0001886) | 2.30212007 |
| 184 | actin-mediated cell contraction (GO:0070252) | 2.29886152 |
| 185 | renal filtration (GO:0097205) | 2.29043173 |
| 186 | substrate-dependent cell migration (GO:0006929) | 2.28904544 |
| 187 | facial nerve structural organization (GO:0021612) | 2.28645612 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.22746461 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.43325019 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.31809782 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.01574875 |
| 5 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.83424615 |
| 6 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.81358465 |
| 7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.66620881 |
| 8 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.51738879 |
| 9 | GATA1_22025678_ChIP-Seq_K562_Human | 2.45776838 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.45510297 |
| 11 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.44552121 |
| 12 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.43838694 |
| 13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.38232284 |
| 14 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.29463518 |
| 15 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.10814914 |
| 16 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.10562579 |
| 17 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.09107972 |
| 18 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 2.09106894 |
| 19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.05569692 |
| 20 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.03528170 |
| 21 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.98062735 |
| 22 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.98013414 |
| 23 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.98013414 |
| 24 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.96951112 |
| 25 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.96127323 |
| 26 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.94393258 |
| 27 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.93330900 |
| 28 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.92742021 |
| 29 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.91315639 |
| 30 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.90097713 |
| 31 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.89507703 |
| 32 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.89462347 |
| 33 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.87642225 |
| 34 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.87288760 |
| 35 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.85769107 |
| 36 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.83342657 |
| 37 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.82420032 |
| 38 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.81289968 |
| 39 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.78525322 |
| 40 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.78091935 |
| 41 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.73371981 |
| 42 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.73091464 |
| 43 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.70058545 |
| 44 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.69766104 |
| 45 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.68661304 |
| 46 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.68361672 |
| 47 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.67390518 |
| 48 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.63748765 |
| 49 | CJUN_26792858_Chip-Seq_BT549_Human | 1.63582092 |
| 50 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.59105622 |
| 51 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.57368910 |
| 52 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.57368910 |
| 53 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.56849489 |
| 54 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.52202313 |
| 55 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.52074718 |
| 56 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.51801185 |
| 57 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.50312788 |
| 58 | P300_19829295_ChIP-Seq_ESCs_Human | 1.50288310 |
| 59 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.49779951 |
| 60 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.46899327 |
| 61 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.46049694 |
| 62 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.45462686 |
| 63 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.43673178 |
| 64 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.43031716 |
| 65 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.41274219 |
| 66 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.41142411 |
| 67 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.39904193 |
| 68 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.37917496 |
| 69 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.37188615 |
| 70 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.36660262 |
| 71 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.36042514 |
| 72 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.33492490 |
| 73 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.32114903 |
| 74 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.30734335 |
| 75 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.29695069 |
| 76 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.29503516 |
| 77 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.27461921 |
| 78 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.27103184 |
| 79 | VDR_22108803_ChIP-Seq_LS180_Human | 1.27011674 |
| 80 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.25583396 |
| 81 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.25263412 |
| 82 | TP53_16413492_ChIP-PET_HCT116_Human | 1.24911851 |
| 83 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.24709187 |
| 84 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.24299943 |
| 85 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.23918514 |
| 86 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.23812761 |
| 87 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.22957437 |
| 88 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.21386580 |
| 89 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.21163640 |
| 90 | AR_25329375_ChIP-Seq_VCAP_Human | 1.20972246 |
| 91 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.20300244 |
| 92 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.19931093 |
| 93 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.18243916 |
| 94 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.17695184 |
| 95 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.17577931 |
| 96 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.16870543 |
| 97 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.13943285 |
| 98 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.13341810 |
| 99 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.13079329 |
| 100 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.12721121 |
| 101 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.12487257 |
| 102 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.11929091 |
| 103 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.11929091 |
| 104 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.11685301 |
| 105 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.11489202 |
| 106 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.11309518 |
| 107 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.11184167 |
| 108 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.11063727 |
| 109 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.10400475 |
| 110 | FUS_26573619_Chip-Seq_HEK293_Human | 1.10359208 |
| 111 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.10170090 |
| 112 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.09535679 |
| 113 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.09081975 |
| 114 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.09027309 |
| 115 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.08961820 |
| 116 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.08149723 |
| 117 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08121872 |
| 118 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.07440794 |
| 119 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.07135958 |
| 120 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.06717418 |
| 121 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06592110 |
| 122 | STAT3_23295773_ChIP-Seq_U87_Human | 1.05977339 |
| 123 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.05796875 |
| 124 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.04940069 |
| 125 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.04442639 |
| 126 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.04376722 |
| 127 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.04262089 |
| 128 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.04165507 |
| 129 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.04072855 |
| 130 | KDM2B_26808549_Chip-Seq_REH_Human | 1.03481646 |
| 131 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.03218272 |
| 132 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.02893535 |
| 133 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.02775537 |
| 134 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.01099169 |
| 135 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.00396299 |
| 136 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.95353359 |
| 137 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95274787 |
| 138 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.92220708 |
| 139 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.90272045 |
| 140 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.89682970 |
| 141 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.88245313 |
| 142 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.87700266 |
| 143 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.85860894 |
| 144 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.84328864 |
| 145 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.83553099 |
| 146 | CBP_21632823_ChIP-Seq_H3396_Human | 0.81866022 |
| 147 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.80443353 |
| 148 | RXR_22108803_ChIP-Seq_LS180_Human | 0.79527008 |
| 149 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.78954610 |
| 150 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.77997018 |
| 151 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.77992165 |
| 152 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.75532736 |
| 153 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.75473219 |
| 154 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.74034226 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005503_abnormal_tendon_morphology | 8.17438422 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 7.32387802 |
| 3 | MP0005275_abnormal_skin_tensile | 5.65948201 |
| 4 | MP0005666_abnormal_adipose_tissue | 3.34925762 |
| 5 | MP0002108_abnormal_muscle_morphology | 3.00722413 |
| 6 | MP0005257_abnormal_intraocular_pressure | 2.94687589 |
| 7 | MP0000751_myopathy | 2.74824493 |
| 8 | MP0005171_absent_coat_pigmentation | 2.74180282 |
| 9 | MP0002971_abnormal_brown_adipose | 2.69379330 |
| 10 | MP0004272_abnormal_basement_membrane | 2.68995169 |
| 11 | MP0005375_adipose_tissue_phenotype | 2.64668355 |
| 12 | MP0001958_emphysema | 2.62355148 |
| 13 | MP0003705_abnormal_hypodermis_morpholog | 2.53565107 |
| 14 | MP0003279_aneurysm | 2.49218153 |
| 15 | MP0001879_abnormal_lymphatic_vessel | 2.29211397 |
| 16 | MP0003724_increased_susceptibility_to | 2.15662796 |
| 17 | MP0005508_abnormal_skeleton_morphology | 2.15055529 |
| 18 | MP0010368_abnormal_lymphatic_system | 2.09021501 |
| 19 | MP0010329_abnormal_lipoprotein_level | 2.07936456 |
| 20 | MP0009115_abnormal_fat_cell | 1.93990097 |
| 21 | MP0000749_muscle_degeneration | 1.93965869 |
| 22 | MP0000003_abnormal_adipose_tissue | 1.78366428 |
| 23 | MP0003868_abnormal_feces_composition | 1.73162601 |
| 24 | MP0004185_abnormal_adipocyte_glucose | 1.72084611 |
| 25 | MP0003959_abnormal_lean_body | 1.72023436 |
| 26 | MP0003828_pulmonary_edema | 1.63017247 |
| 27 | MP0004215_abnormal_myocardial_fiber | 1.62125278 |
| 28 | MP0003950_abnormal_plasma_membrane | 1.55071394 |
| 29 | MP0005369_muscle_phenotype | 1.49463144 |
| 30 | MP0004484_altered_response_of | 1.49046793 |
| 31 | MP0002837_dystrophic_cardiac_calcinosis | 1.48506048 |
| 32 | MP0002970_abnormal_white_adipose | 1.46033084 |
| 33 | MP0003941_abnormal_skin_development | 1.45365380 |
| 34 | MP0003690_abnormal_glial_cell | 1.45222208 |
| 35 | MP0004084_abnormal_cardiac_muscle | 1.41162566 |
| 36 | MP0002060_abnormal_skin_morphology | 1.40856256 |
| 37 | MP0000013_abnormal_adipose_tissue | 1.39701700 |
| 38 | MP0009250_abnormal_appendicular_skeleto | 1.39174071 |
| 39 | MP0004145_abnormal_muscle_electrophysio | 1.37806430 |
| 40 | MP0003011_delayed_dark_adaptation | 1.36254330 |
| 41 | MP0003186_abnormal_redox_activity | 1.33277200 |
| 42 | MP0005334_abnormal_fat_pad | 1.30141800 |
| 43 | MP0002295_abnormal_pulmonary_circulatio | 1.28982467 |
| 44 | MP0005365_abnormal_bile_salt | 1.27728204 |
| 45 | MP0003385_abnormal_body_wall | 1.24729657 |
| 46 | MP0002933_joint_inflammation | 1.24698049 |
| 47 | MP0000750_abnormal_muscle_regeneration | 1.23190974 |
| 48 | MP0008775_abnormal_heart_ventricle | 1.22710239 |
| 49 | MP0003646_muscle_fatigue | 1.22040088 |
| 50 | MP0005620_abnormal_muscle_contractility | 1.21912298 |
| 51 | MP0005390_skeleton_phenotype | 1.20295982 |
| 52 | MP0005164_abnormal_response_to | 1.18578763 |
| 53 | MP0002118_abnormal_lipid_homeostasis | 1.17819673 |
| 54 | MP0003191_abnormal_cellular_cholesterol | 1.17407531 |
| 55 | MP0005165_increased_susceptibility_to | 1.17127194 |
| 56 | MP0005023_abnormal_wound_healing | 1.16732742 |
| 57 | MP0005535_abnormal_body_temperature | 1.16394714 |
| 58 | MP0005330_cardiomyopathy | 1.16369541 |
| 59 | MP0004134_abnormal_chest_morphology | 1.16311876 |
| 60 | MP0004036_abnormal_muscle_relaxation | 1.16262847 |
| 61 | MP0010386_abnormal_urinary_bladder | 1.15671919 |
| 62 | MP0005595_abnormal_vascular_smooth | 1.12427777 |
| 63 | MP0002972_abnormal_cardiac_muscle | 1.11622600 |
| 64 | MP0000343_altered_response_to | 1.11587012 |
| 65 | MP0002139_abnormal_hepatobiliary_system | 1.10307837 |
| 66 | MP0000767_abnormal_smooth_muscle | 1.08285897 |
| 67 | MP0004147_increased_porphyrin_level | 1.06215882 |
| 68 | MP0005623_abnormal_meninges_morphology | 1.04172704 |
| 69 | MP0000249_abnormal_blood_vessel | 1.03911810 |
| 70 | MP0002106_abnormal_muscle_physiology | 1.03394175 |
| 71 | MP0002249_abnormal_larynx_morphology | 1.02079640 |
| 72 | MP0003045_fibrosis | 1.00822539 |
| 73 | MP0005167_abnormal_blood-brain_barrier | 0.99548055 |
| 74 | MP0005360_urolithiasis | 0.99409635 |
| 75 | MP0006054_spinal_hemorrhage | 0.98170112 |
| 76 | MP0006292_abnormal_olfactory_placode | 0.98123765 |
| 77 | MP0003136_yellow_coat_color | 0.97673449 |
| 78 | MP0005670_abnormal_white_adipose | 0.96716211 |
| 79 | MP0004782_abnormal_surfactant_physiolog | 0.95766960 |
| 80 | MP0001986_abnormal_taste_sensitivity | 0.95397439 |
| 81 | MP0000566_synostosis | 0.93936531 |
| 82 | MP0001188_hyperpigmentation | 0.93478874 |
| 83 | MP0000534_abnormal_ureter_morphology | 0.92139840 |
| 84 | MP0002638_abnormal_pupillary_reflex | 0.90820876 |
| 85 | MP0005646_abnormal_pituitary_gland | 0.90272854 |
| 86 | MP0002896_abnormal_bone_mineralization | 0.90183486 |
| 87 | MP0002998_abnormal_bone_remodeling | 0.88827286 |
| 88 | MP0001661_extended_life_span | 0.88199867 |
| 89 | MP0005448_abnormal_energy_balance | 0.87551572 |
| 90 | MP0001544_abnormal_cardiovascular_syste | 0.87321829 |
| 91 | MP0005385_cardiovascular_system_phenoty | 0.87321829 |
| 92 | MP0005647_abnormal_sex_gland | 0.86878886 |
| 93 | MP0000163_abnormal_cartilage_morphology | 0.84082058 |
| 94 | MP0003137_abnormal_impulse_conducting | 0.82318150 |
| 95 | MP0005452_abnormal_adipose_tissue | 0.82256985 |
| 96 | MP0004883_abnormal_blood_vessel | 0.81208473 |
| 97 | MP0000049_abnormal_middle_ear | 0.80494842 |
| 98 | MP0002133_abnormal_respiratory_system | 0.79888170 |
| 99 | MP0005388_respiratory_system_phenotype | 0.79888170 |
| 100 | MP0002168_other_aberrant_phenotype | 0.79685020 |
| 101 | MP0006138_congestive_heart_failure | 0.79148431 |
| 102 | MP0008004_abnormal_stomach_pH | 0.78527155 |
| 103 | MP0002115_abnormal_skeleton_extremities | 0.77774719 |
| 104 | MP0000759_abnormal_skeletal_muscle | 0.77079438 |
| 105 | MP0009780_abnormal_chondrocyte_physiolo | 0.76415199 |
| 106 | MP0009697_abnormal_copulation | 0.76001404 |
| 107 | MP0002909_abnormal_adrenal_gland | 0.73988350 |
| 108 | MP0009379_abnormal_foot_pigmentation | 0.73974117 |
| 109 | MP0003091_abnormal_cell_migration | 0.73695614 |
| 110 | MP0001542_abnormal_bone_strength | 0.72842137 |
| 111 | MP0005084_abnormal_gallbladder_morpholo | 0.70483067 |
| 112 | MP0004133_heterotaxia | 0.70111182 |
| 113 | MP0004087_abnormal_muscle_fiber | 0.69941084 |
| 114 | MP0009764_decreased_sensitivity_to | 0.69906008 |
| 115 | MP0002102_abnormal_ear_morphology | 0.69237776 |
| 116 | MP0004085_abnormal_heartbeat | 0.69138055 |
| 117 | MP0002128_abnormal_blood_circulation | 0.67706296 |
| 118 | MP0001243_abnormal_dermal_layer | 0.67023021 |
| 119 | MP0002109_abnormal_limb_morphology | 0.66072460 |
| 120 | MP0005409_darkened_coat_color | 0.65827297 |
| 121 | MP0004130_abnormal_muscle_cell | 0.65769667 |
| 122 | MP0000747_muscle_weakness | 0.64321662 |
| 123 | MP0001614_abnormal_blood_vessel | 0.63945710 |
| 124 | MP0002938_white_spotting | 0.63290949 |
| 125 | MP0003566_abnormal_cell_adhesion | 0.63105581 |
| 126 | MP0001851_eye_inflammation | 0.62961879 |
| 127 | MP0005085_abnormal_gallbladder_physiolo | 0.60937934 |
| 128 | MP0009384_cardiac_valve_regurgitation | 0.60863202 |
| 129 | MP0002113_abnormal_skeleton_development | 0.60182673 |
| 130 | MP0002078_abnormal_glucose_homeostasis | 0.59687624 |
| 131 | MP0002932_abnormal_joint_morphology | 0.59556625 |
| 132 | MP0001501_abnormal_sleep_pattern | 0.59252619 |
| 133 | MP0001299_abnormal_eye_distance/ | 0.56569930 |
| 134 | MP0002089_abnormal_postnatal_growth/wei | 0.56214824 |
| 135 | MP0005332_abnormal_amino_acid | 0.55939932 |
| 136 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.55900521 |
| 137 | MP0000733_abnormal_muscle_development | 0.55566040 |
| 138 | MP0002006_tumorigenesis | 0.55353261 |
| 139 | MP0001533_abnormal_skeleton_physiology | 0.54547688 |
| 140 | MP0002876_abnormal_thyroid_physiology | 0.53938728 |
| 141 | MP0010630_abnormal_cardiac_muscle | 0.52962379 |
| 142 | MP0001270_distended_abdomen | 0.52841390 |
| 143 | MP0002116_abnormal_craniofacial_bone | 0.52233732 |
| 144 | MP0003938_abnormal_ear_development | 0.50516976 |
| 145 | MP0003935_abnormal_craniofacial_develop | 0.49935236 |
| 146 | MP0000230_abnormal_systemic_arterial | 0.47753064 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement deficiency (HP:0004431) | 6.05992002 |
| 2 | Broad metatarsal (HP:0001783) | 5.37870648 |
| 3 | Abnormality of complement system (HP:0005339) | 5.26675097 |
| 4 | Pulmonary artery stenosis (HP:0004415) | 4.83838942 |
| 5 | Oligomenorrhea (HP:0000876) | 4.61366386 |
| 6 | Systemic lupus erythematosus (HP:0002725) | 4.59330439 |
| 7 | Follicular hyperkeratosis (HP:0007502) | 4.58227094 |
| 8 | Protrusio acetabuli (HP:0003179) | 4.47251756 |
| 9 | Acanthosis nigricans (HP:0000956) | 4.01457957 |
| 10 | Duplicated collecting system (HP:0000081) | 3.92625676 |
| 11 | Neonatal short-limb short stature (HP:0008921) | 3.92494291 |
| 12 | Type 1 muscle fiber predominance (HP:0003803) | 3.67534169 |
| 13 | Arterial tortuosity (HP:0005116) | 3.65015914 |
| 14 | Premature rupture of membranes (HP:0001788) | 3.60788349 |
| 15 | Hyperlipoproteinemia (HP:0010980) | 3.58941394 |
| 16 | Abnormality of the renal collecting system (HP:0004742) | 3.54910722 |
| 17 | Hypertriglyceridemia (HP:0002155) | 3.53238931 |
| 18 | Increased connective tissue (HP:0009025) | 3.46041332 |
| 19 | Soft skin (HP:0000977) | 3.44351929 |
| 20 | Muscle fiber splitting (HP:0003555) | 3.41447503 |
| 21 | Glomerulonephritis (HP:0000099) | 3.29930534 |
| 22 | Ankle contracture (HP:0006466) | 3.29071584 |
| 23 | Aortic dissection (HP:0002647) | 3.26522424 |
| 24 | Atrial fibrillation (HP:0005110) | 3.15849647 |
| 25 | Wrist flexion contracture (HP:0001239) | 3.15089446 |
| 26 | Dilatation of the ascending aorta (HP:0005111) | 2.94571594 |
| 27 | Striae distensae (HP:0001065) | 2.93577923 |
| 28 | Corneal dystrophy (HP:0001131) | 2.90653282 |
| 29 | Ectopia lentis (HP:0001083) | 2.86356030 |
| 30 | Wormian bones (HP:0002645) | 2.86226850 |
| 31 | Spinal rigidity (HP:0003306) | 2.86042999 |
| 32 | Keratoconus (HP:0000563) | 2.85523920 |
| 33 | Increased corneal curvature (HP:0100692) | 2.85523920 |
| 34 | Vertebral compression fractures (HP:0002953) | 2.84406534 |
| 35 | Metaphyseal dysplasia (HP:0100255) | 2.79122100 |
| 36 | Primary atrial arrhythmia (HP:0001692) | 2.77535363 |
| 37 | Aortic valve stenosis (HP:0001650) | 2.75489243 |
| 38 | Flat cornea (HP:0007720) | 2.75156221 |
| 39 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.74055364 |
| 40 | Chronic hepatic failure (HP:0100626) | 2.73780676 |
| 41 | Round ear (HP:0100830) | 2.70710570 |
| 42 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.66582253 |
| 43 | Abnormality of molar morphology (HP:0011070) | 2.66517670 |
| 44 | Abnormality of molar (HP:0011077) | 2.66517670 |
| 45 | Calf muscle hypertrophy (HP:0008981) | 2.64663802 |
| 46 | Ventricular tachycardia (HP:0004756) | 2.63863809 |
| 47 | Mitral valve prolapse (HP:0001634) | 2.63789991 |
| 48 | Osteolytic defects of the hand bones (HP:0009699) | 2.63357992 |
| 49 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.63357992 |
| 50 | Supraventricular arrhythmia (HP:0005115) | 2.62367982 |
| 51 | Distal lower limb muscle weakness (HP:0009053) | 2.61762734 |
| 52 | Congenital, generalized hypertrichosis (HP:0004540) | 2.61510982 |
| 53 | Nephritis (HP:0000123) | 2.59925785 |
| 54 | Myocardial infarction (HP:0001658) | 2.59512245 |
| 55 | Supraventricular tachycardia (HP:0004755) | 2.58265336 |
| 56 | Skin nodule (HP:0200036) | 2.58122201 |
| 57 | Hypoplasia of the iris (HP:0007676) | 2.57408983 |
| 58 | Lipoatrophy (HP:0100578) | 2.53272470 |
| 59 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.51004175 |
| 60 | Blue sclerae (HP:0000592) | 2.48263882 |
| 61 | Bone cyst (HP:0012062) | 2.47706074 |
| 62 | Limited hip movement (HP:0008800) | 2.47100036 |
| 63 | Back pain (HP:0003418) | 2.44204961 |
| 64 | Mitral stenosis (HP:0001718) | 2.43343712 |
| 65 | Polycythemia (HP:0001901) | 2.42582656 |
| 66 | Bladder diverticulum (HP:0000015) | 2.40893396 |
| 67 | Aneurysm (HP:0002617) | 2.37738292 |
| 68 | Prolonged QT interval (HP:0001657) | 2.36923908 |
| 69 | Hypoalphalipoproteinemia (HP:0003233) | 2.35969699 |
| 70 | Insulin resistance (HP:0000855) | 2.34615423 |
| 71 | Difficulty running (HP:0009046) | 2.33216747 |
| 72 | Joint stiffness (HP:0001387) | 2.31956854 |
| 73 | Pigmentary retinal degeneration (HP:0001146) | 2.30898794 |
| 74 | Xanthomatosis (HP:0000991) | 2.30384573 |
| 75 | Slender build (HP:0001533) | 2.29658876 |
| 76 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.27338234 |
| 77 | Shallow orbits (HP:0000586) | 2.26315676 |
| 78 | Abnormality of the calf musculature (HP:0001430) | 2.25459905 |
| 79 | Abnormality of the dental pulp (HP:0006479) | 2.25215712 |
| 80 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.22334817 |
| 81 | Venous abnormality (HP:0002624) | 2.20656964 |
| 82 | Enlarged penis (HP:0000040) | 2.19500406 |
| 83 | Hemorrhage of the eye (HP:0011885) | 2.18075646 |
| 84 | Deep venous thrombosis (HP:0002625) | 2.15355752 |
| 85 | Chromsome breakage (HP:0040012) | 2.14972760 |
| 86 | Long foot (HP:0001833) | 2.14043306 |
| 87 | Hyporeflexia of lower limbs (HP:0002600) | 2.13745213 |
| 88 | Asymmetric septal hypertrophy (HP:0001670) | 2.13536551 |
| 89 | Bell-shaped thorax (HP:0001591) | 2.13457119 |
| 90 | Increased variability in muscle fiber diameter (HP:0003557) | 2.12153146 |
| 91 | Infantile muscular hypotonia (HP:0008947) | 2.12013506 |
| 92 | Fragile skin (HP:0001030) | 2.11841696 |
| 93 | Abnormal delivery (HP:0001787) | 2.10842093 |
| 94 | Hyperextensible skin (HP:0000974) | 2.10766266 |
| 95 | Peritonitis (HP:0002586) | 2.10690237 |
| 96 | Epidermoid cyst (HP:0200040) | 2.09780278 |
| 97 | Wide anterior fontanel (HP:0000260) | 2.07029558 |
| 98 | Natal tooth (HP:0000695) | 2.06550466 |
| 99 | Sudden death (HP:0001699) | 2.06457333 |
| 100 | Joint hemorrhage (HP:0005261) | 2.06138206 |
| 101 | Thick nail (HP:0001805) | 2.05770527 |
| 102 | Advanced eruption of teeth (HP:0006288) | 2.03039271 |
| 103 | Right ventricular cardiomyopathy (HP:0011663) | 2.01561410 |
| 104 | Aortic aneurysm (HP:0004942) | 2.01477708 |
| 105 | Spondylolisthesis (HP:0003302) | 2.01037440 |
| 106 | Abnormality of permanent molar morphology (HP:0011071) | 2.00987089 |
| 107 | Abnormality of the dental root (HP:0006486) | 2.00987089 |
| 108 | Taurodontia (HP:0000679) | 2.00987089 |
| 109 | Bulbar palsy (HP:0001283) | 2.00475042 |
| 110 | Ovoid vertebral bodies (HP:0003300) | 1.98806996 |
| 111 | Short hallux (HP:0010109) | 1.98317917 |
| 112 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.98225216 |
| 113 | Neck muscle weakness (HP:0000467) | 1.97338521 |
| 114 | Submucous cleft hard palate (HP:0000176) | 1.95769154 |
| 115 | Narrow nasal bridge (HP:0000446) | 1.95699708 |
| 116 | Hypoplastic ischia (HP:0003175) | 1.95397652 |
| 117 | Cervical subluxation (HP:0003308) | 1.95314235 |
| 118 | Mild short stature (HP:0003502) | 1.94046653 |
| 119 | Amyloidosis (HP:0011034) | 1.93872893 |
| 120 | Hip contracture (HP:0003273) | 1.93730185 |
| 121 | Septo-optic dysplasia (HP:0100842) | 1.93516668 |
| 122 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.90822045 |
| 123 | Steatorrhea (HP:0002570) | 1.88269637 |
| 124 | Abnormality of dentin (HP:0010299) | 1.87342106 |
| 125 | Hypercholesterolemia (HP:0003124) | 1.85457437 |
| 126 | Prominent supraorbital ridges (HP:0000336) | 1.84742319 |
| 127 | Atrophic scars (HP:0001075) | 1.83085934 |
| 128 | Lymphangioma (HP:0100764) | 1.82298643 |
| 129 | Joint laxity (HP:0001388) | 1.81740529 |
| 130 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.79904637 |
| 131 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.78741895 |
| 132 | Coxa vara (HP:0002812) | 1.78461088 |
| 133 | Vascular tortuosity (HP:0004948) | 1.78439355 |
| 134 | Prostate neoplasm (HP:0100787) | 1.78029663 |
| 135 | Portal hypertension (HP:0001409) | 1.77533279 |
| 136 | Conical tooth (HP:0000698) | 1.77212052 |
| 137 | Broad ribs (HP:0000885) | 1.75609377 |
| 138 | Aplasia cutis congenita (HP:0001057) | 1.75436912 |
| 139 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.74602926 |
| 140 | Hypolipoproteinemia (HP:0010981) | 1.74500402 |
| 141 | Fat malabsorption (HP:0002630) | 1.73702587 |
| 142 | Cerebral aneurysm (HP:0004944) | 1.73561544 |
| 143 | Chondrocalcinosis (HP:0000934) | 1.73486903 |
| 144 | Abnormal eating behavior (HP:0100738) | 1.73313834 |
| 145 | Axonal loss (HP:0003447) | 1.72974779 |
| 146 | Abnormal EKG (HP:0003115) | 1.72964136 |
| 147 | Bradycardia (HP:0001662) | 1.71629950 |
| 148 | Abnormality of the hepatic vasculature (HP:0006707) | 1.69773684 |
| 149 | Overgrowth (HP:0001548) | 1.69444545 |
| 150 | Aortic regurgitation (HP:0001659) | 1.65692406 |
| 151 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.64820473 |
| 152 | Absent/shortened dynein arms (HP:0200106) | 1.64820473 |
| 153 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.64556451 |
| 154 | Abnormality of the sella turcica (HP:0002679) | 1.63982571 |
| 155 | Congenital hepatic fibrosis (HP:0002612) | 1.63816440 |
| 156 | Abnormality of the ischium (HP:0003174) | 1.61411184 |
| 157 | Cardiovascular calcification (HP:0011915) | 1.60630549 |
| 158 | Muscular dystrophy (HP:0003560) | 1.60215299 |
| 159 | Biconcave vertebral bodies (HP:0004586) | 1.59987194 |
| 160 | Abnormality of the nasal septum (HP:0000419) | 1.59621103 |
| 161 | Venous insufficiency (HP:0005293) | 1.59418406 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 6.34007478 |
| 2 | TIE1 | 3.89245391 |
| 3 | ZAK | 3.68411240 |
| 4 | RIPK1 | 3.02299950 |
| 5 | OBSCN | 2.36627227 |
| 6 | ERN1 | 2.33770770 |
| 7 | MAP2K7 | 2.28074738 |
| 8 | TRPM7 | 2.21668111 |
| 9 | CASK | 2.06423311 |
| 10 | TNIK | 2.01979879 |
| 11 | PINK1 | 1.95546637 |
| 12 | TGFBR2 | 1.91462431 |
| 13 | ABL2 | 1.74268685 |
| 14 | MUSK | 1.71565137 |
| 15 | EPHA3 | 1.71430183 |
| 16 | PKN1 | 1.71116523 |
| 17 | MYLK | 1.66943755 |
| 18 | MAPKAPK3 | 1.66552242 |
| 19 | TRIB3 | 1.62631538 |
| 20 | LATS2 | 1.60778131 |
| 21 | IRAK3 | 1.59021118 |
| 22 | GRK5 | 1.56776944 |
| 23 | EIF2AK2 | 1.55334396 |
| 24 | NUAK1 | 1.55027572 |
| 25 | TTN | 1.48806000 |
| 26 | GRK1 | 1.41279466 |
| 27 | PDGFRA | 1.39134698 |
| 28 | MAPK4 | 1.38018556 |
| 29 | TESK1 | 1.37809361 |
| 30 | PAK2 | 1.32149397 |
| 31 | IRAK4 | 1.31446368 |
| 32 | ERBB3 | 1.31072825 |
| 33 | PHKG2 | 1.28698163 |
| 34 | PHKG1 | 1.28698163 |
| 35 | EPHB2 | 1.23778102 |
| 36 | TNK2 | 1.22370797 |
| 37 | NEK6 | 1.21951127 |
| 38 | TEC | 1.20812874 |
| 39 | MOS | 1.20642269 |
| 40 | CAMK1G | 1.16435855 |
| 41 | NLK | 1.16262566 |
| 42 | PRKCE | 1.13240224 |
| 43 | DMPK | 1.11086174 |
| 44 | TXK | 1.10770875 |
| 45 | LATS1 | 1.09072289 |
| 46 | PRPF4B | 1.09025505 |
| 47 | EEF2K | 1.07102334 |
| 48 | GRK7 | 1.05011181 |
| 49 | TYK2 | 1.03465303 |
| 50 | IRAK1 | 1.03009424 |
| 51 | TGFBR1 | 1.02475801 |
| 52 | CAMK1D | 0.99022001 |
| 53 | BMPR2 | 0.95978729 |
| 54 | MKNK2 | 0.93476176 |
| 55 | JAK1 | 0.92492661 |
| 56 | PDK2 | 0.90930935 |
| 57 | MAP3K14 | 0.90647312 |
| 58 | PIK3CA | 0.90589804 |
| 59 | DDR2 | 0.90260317 |
| 60 | PTK2 | 0.90101367 |
| 61 | CAMK1 | 0.88826335 |
| 62 | STK3 | 0.88435401 |
| 63 | FRK | 0.88019888 |
| 64 | GSK3A | 0.87975211 |
| 65 | MET | 0.86631636 |
| 66 | SGK2 | 0.86430973 |
| 67 | ADRBK2 | 0.85279447 |
| 68 | MAP2K1 | 0.84663783 |
| 69 | MAPK13 | 0.83819606 |
| 70 | JAK3 | 0.82750931 |
| 71 | SIK3 | 0.78608439 |
| 72 | NEK9 | 0.78411783 |
| 73 | MAPK15 | 0.77771435 |
| 74 | BMPR1B | 0.76967558 |
| 75 | MAP3K7 | 0.74001284 |
| 76 | YES1 | 0.73835378 |
| 77 | PRKAA1 | 0.73659188 |
| 78 | PRKACG | 0.73374439 |
| 79 | PRKD1 | 0.72282241 |
| 80 | CDK8 | 0.72196309 |
| 81 | PRKCH | 0.72171853 |
| 82 | ROCK1 | 0.72093432 |
| 83 | STK38L | 0.71929651 |
| 84 | AKT3 | 0.71394854 |
| 85 | FER | 0.70663489 |
| 86 | CSK | 0.69908279 |
| 87 | MAPK7 | 0.69729638 |
| 88 | PTK2B | 0.69013062 |
| 89 | CDK6 | 0.68950466 |
| 90 | FGFR3 | 0.67246523 |
| 91 | PLK2 | 0.66055021 |
| 92 | MAP3K3 | 0.64509962 |
| 93 | PRKAA2 | 0.63876613 |
| 94 | ILK | 0.63732876 |
| 95 | SIK1 | 0.63721367 |
| 96 | LMTK2 | 0.63395655 |
| 97 | RET | 0.63235411 |
| 98 | NTRK1 | 0.62550675 |
| 99 | MAP3K13 | 0.61983689 |
| 100 | MAPK12 | 0.61424830 |
| 101 | PDGFRB | 0.60812338 |
| 102 | ARAF | 0.60017505 |
| 103 | CDK3 | 0.58079122 |
| 104 | PRKD2 | 0.57681566 |
| 105 | PIK3CG | 0.57585573 |
| 106 | ADRBK1 | 0.56331837 |
| 107 | SGK494 | 0.56148743 |
| 108 | SGK223 | 0.56148743 |
| 109 | EPHB1 | 0.56136335 |
| 110 | JAK2 | 0.55493960 |
| 111 | IKBKB | 0.55141999 |
| 112 | CDC42BPA | 0.54492619 |
| 113 | KIT | 0.54331118 |
| 114 | CAMK2D | 0.53120540 |
| 115 | PRKG1 | 0.52868421 |
| 116 | ABL1 | 0.52487794 |
| 117 | IGF1R | 0.52483082 |
| 118 | BRD4 | 0.51624950 |
| 119 | MAPK3 | 0.51398106 |
| 120 | MTOR | 0.50460339 |
| 121 | CAMK4 | 0.50348593 |
| 122 | DAPK3 | 0.50001858 |
| 123 | PDPK1 | 0.49936162 |
| 124 | MAPKAPK5 | 0.48829362 |
| 125 | PRKACB | 0.48811152 |
| 126 | MKNK1 | 0.47964248 |
| 127 | STK38 | 0.45937939 |
| 128 | DYRK2 | 0.44450491 |
| 129 | KDR | 0.44056134 |
| 130 | CAMK2G | 0.44051792 |
| 131 | IRAK2 | 0.41987562 |
| 132 | CAMK2A | 0.41355746 |
| 133 | SGK3 | 0.38509353 |
| 134 | STK24 | 0.38028156 |
| 135 | VRK1 | 0.37967357 |
| 136 | INSR | 0.37446825 |
| 137 | PRKACA | 0.37293317 |
| 138 | MAP3K6 | 0.36675494 |
| 139 | MAPK1 | 0.36260061 |
| 140 | WNK1 | 0.36228600 |
| 141 | RPS6KA3 | 0.34419496 |
| 142 | BCR | 0.34045038 |
| 143 | FGFR2 | 0.32640715 |
| 144 | FGFR4 | 0.31523315 |
| 145 | IKBKE | 0.30395286 |
| 146 | SRC | 0.30101269 |
| 147 | MARK2 | 0.29372568 |
| 148 | ROCK2 | 0.29326435 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ECM-receptor interaction_Homo sapiens_hsa04512 | 3.66987574 |
| 2 | PPAR signaling pathway_Homo sapiens_hsa03320 | 3.53697047 |
| 3 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 3.16553892 |
| 4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.96313729 |
| 5 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.74603495 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.66974329 |
| 7 | Histidine metabolism_Homo sapiens_hsa00340 | 2.66070392 |
| 8 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.61464235 |
| 9 | Malaria_Homo sapiens_hsa05144 | 2.53012628 |
| 10 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.50211007 |
| 11 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.39444646 |
| 12 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.31338509 |
| 13 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.28012917 |
| 14 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.27533506 |
| 15 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.20717141 |
| 16 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.15567068 |
| 17 | Retinol metabolism_Homo sapiens_hsa00830 | 2.01333228 |
| 18 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.00489065 |
| 19 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.97890921 |
| 20 | Focal adhesion_Homo sapiens_hsa04510 | 1.94285101 |
| 21 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.89236434 |
| 22 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.87768452 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.77427893 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.74870873 |
| 25 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.74394646 |
| 26 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.67140745 |
| 27 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.62253352 |
| 28 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.61501112 |
| 29 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.60407110 |
| 30 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.51139948 |
| 31 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.49889383 |
| 32 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.42669031 |
| 33 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.42631134 |
| 34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.40529947 |
| 35 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.39357223 |
| 36 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.38222534 |
| 37 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.37122445 |
| 38 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.36278693 |
| 39 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.35754239 |
| 40 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.30226793 |
| 41 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.29179204 |
| 42 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.29012474 |
| 43 | Amoebiasis_Homo sapiens_hsa05146 | 1.28278257 |
| 44 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.27526630 |
| 45 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.25255099 |
| 46 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.24158490 |
| 47 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.24009853 |
| 48 | Viral myocarditis_Homo sapiens_hsa05416 | 1.22438811 |
| 49 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.20968283 |
| 50 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.20505310 |
| 51 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.19513648 |
| 52 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.18938307 |
| 53 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.17361632 |
| 54 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.17233295 |
| 55 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.16932033 |
| 56 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.11800748 |
| 57 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.10460535 |
| 58 | Morphine addiction_Homo sapiens_hsa05032 | 1.09170520 |
| 59 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.08789622 |
| 60 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.08618008 |
| 61 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.07957225 |
| 62 | Taste transduction_Homo sapiens_hsa04742 | 1.07951242 |
| 63 | Bile secretion_Homo sapiens_hsa04976 | 1.07641984 |
| 64 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.05917383 |
| 65 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.05687042 |
| 66 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.05654900 |
| 67 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.04646703 |
| 68 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.04081944 |
| 69 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.03732086 |
| 70 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.03344378 |
| 71 | Other glycan degradation_Homo sapiens_hsa00511 | 1.02285184 |
| 72 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.01080216 |
| 73 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.00470528 |
| 74 | Adherens junction_Homo sapiens_hsa04520 | 0.98946006 |
| 75 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.96823617 |
| 76 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.96701572 |
| 77 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.94825242 |
| 78 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.94071942 |
| 79 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.92407555 |
| 80 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.92210176 |
| 81 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.90702850 |
| 82 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.89871356 |
| 83 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.87400720 |
| 84 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.86534463 |
| 85 | Allograft rejection_Homo sapiens_hsa05330 | 0.84418886 |
| 86 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.84019709 |
| 87 | Renin secretion_Homo sapiens_hsa04924 | 0.81748395 |
| 88 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.81425211 |
| 89 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.79676011 |
| 90 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.79386611 |
| 91 | Pathways in cancer_Homo sapiens_hsa05200 | 0.78653364 |
| 92 | Lysine degradation_Homo sapiens_hsa00310 | 0.77896373 |
| 93 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.77446389 |
| 94 | Peroxisome_Homo sapiens_hsa04146 | 0.76835911 |
| 95 | Nicotine addiction_Homo sapiens_hsa05033 | 0.75462691 |
| 96 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.75022227 |
| 97 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.74365000 |
| 98 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.73665027 |
| 99 | Circadian entrainment_Homo sapiens_hsa04713 | 0.73397626 |
| 100 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.72088678 |
| 101 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.71518248 |
| 102 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.71302321 |
| 103 | ABC transporters_Homo sapiens_hsa02010 | 0.70952740 |
| 104 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.70948668 |
| 105 | Measles_Homo sapiens_hsa05162 | 0.70383525 |
| 106 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.69091742 |
| 107 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.69051744 |
| 108 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.67818426 |
| 109 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.65955146 |
| 110 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.65880490 |
| 111 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.65457107 |
| 112 | Melanoma_Homo sapiens_hsa05218 | 0.64663854 |
| 113 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.62764550 |
| 114 | Circadian rhythm_Homo sapiens_hsa04710 | 0.62427589 |
| 115 | Axon guidance_Homo sapiens_hsa04360 | 0.61396388 |
| 116 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.60291423 |
| 117 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59403613 |
| 118 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.59232373 |
| 119 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.58683199 |
| 120 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.58606221 |
| 121 | Asthma_Homo sapiens_hsa05310 | 0.58544785 |
| 122 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57548836 |
| 123 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.57337840 |
| 124 | Prostate cancer_Homo sapiens_hsa05215 | 0.57092853 |
| 125 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.56712258 |
| 126 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.56280637 |
| 127 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.55551004 |
| 128 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.55048998 |
| 129 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.53084501 |
| 130 | Platelet activation_Homo sapiens_hsa04611 | 0.52674579 |
| 131 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.52429371 |
| 132 | Prion diseases_Homo sapiens_hsa05020 | 0.52152396 |
| 133 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.51978535 |
| 134 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.51547849 |
| 135 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.51249695 |
| 136 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.51170190 |
| 137 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.50949611 |
| 138 | Insulin resistance_Homo sapiens_hsa04931 | 0.50546081 |
| 139 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49952417 |
| 140 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.49796671 |
| 141 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.49645460 |
| 142 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.49164733 |
| 143 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.49030382 |
| 144 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.46369230 |
| 145 | Pertussis_Homo sapiens_hsa05133 | 0.46353746 |
| 146 | Insulin secretion_Homo sapiens_hsa04911 | 0.45273658 |
| 147 | Mineral absorption_Homo sapiens_hsa04978 | 0.45017310 |
| 148 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.41702322 |
| 149 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.40783641 |
| 150 | Carbon metabolism_Homo sapiens_hsa01200 | 0.40526592 |
| 151 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.38859114 |
| 152 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.35334337 |
| 153 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.32451849 |
| 154 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.30238024 |
| 155 | Sulfur relay system_Homo sapiens_hsa04122 | 0.29516883 |
| 156 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.22784165 |
| 157 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.22569779 |
| 158 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.19875299 |
| 159 | Gap junction_Homo sapiens_hsa04540 | 0.17316452 |

